ReviewCancers2023

Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis.

Jonathan N Priantti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.